Skip to main content
Patients in clinical remission are most likely to benefit from autologous transplantation, with the exception of patients with clear cell histology.

Ovarian Carcinoma Treated with High-Dose Chemotherapy and Autologous Stem Cell Transplantation

July 1, 2004

Patients in clinical remission are most likely to benefit from autologous transplantation, with the exception of patients with clear cell histology.